Pfizer is currently trading at Rs. 1752.50, down by -34.95 points or 1.96% from its previous closing of Rs. 1787.45 on the BSE.
The scrip opened at Rs. 1780.00 and has touched a high and low of Rs. 1780.00 and Rs. 1736.05 respectively. So far 859 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2055.00 on 09-Sep-2016 and a 52 week low of Rs. 1625.00 on 08-Jun-2017.
Last one week high and low of the scrip stood at Rs. 1823.05 and Rs. 1736.05 respectively. The current market cap of the company is Rs. 8060.75 crore.
The promoters holding in the company stood at 63.92%, while Institutions and Non-Institutions held 13.98% and 22.09% respectively.
Pfizer has reported 28.57% fall in its net profit at Rs 57.17 crore for first quarter ended June 30, 2017, as compared to Rs 80.04 crore for the same quarter in the previous year. Total income of the company decreased by 15.22% at Rs 459.86 crore for Q1FY18 as compared Rs 542.41 crore for the corresponding quarter previous year.
Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.